These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21437912)

  • 1. Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations.
    Rena O; Boldorini LR; Gaudino E; Casadio C
    J Surg Oncol; 2011 Nov; 104(6):701-5. PubMed ID: 21437912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma.
    Enomoto Y; Kasai T; Takeda M; Takano M; Morita K; Kadota E; Iizuka N; Maruyama H; Haratake J; Kojima Y; Ikeda N; Nonomura A
    Pathol Int; 2012 Apr; 62(4):226-31. PubMed ID: 22449226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma.
    Foster JM; Gatalica Z; Lilleberg S; Haynatzki G; Loggie BW
    Ann Surg Oncol; 2009 Jan; 16(1):152-8. PubMed ID: 18998063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue and serum EGFR as prognostic factors in malignant pleural mesothelioma.
    Gaafar R; Bahnassy A; Abdelsalam I; Kamel MM; Helal A; Abdel-Hamid A; Eldin NA; Mokhtar N
    Lung Cancer; 2010 Oct; 70(1):43-50. PubMed ID: 20347505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor mutations in malignant pleural and peritoneal mesothelioma.
    Enomoto Y; Kasai T; Takeda M; Takano M; Morita K; Kadota E; Iizuka N; Maruyama H; Haratake J; Kojima Y; Ikeda N; Inatsugi N; Nonomura A
    J Clin Pathol; 2012 Jun; 65(6):522-7. PubMed ID: 22412050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
    Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
    Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations.
    Destro A; Ceresoli GL; Falleni M; Zucali PA; Morenghi E; Bianchi P; Pellegrini C; Cordani N; Vaira V; Alloisio M; Rizzi A; Bosari S; Roncalli M
    Lung Cancer; 2006 Feb; 51(2):207-15. PubMed ID: 16384623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
    Kumar-Singh S; Segers K; Rodeck U; Backhovens H; Bogers J; Weyler J; Van Broeckhoven C; Van Marck E
    J Pathol; 1997 Jan; 181(1):67-74. PubMed ID: 9072005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.
    Yang YL; Xu KL; Zhou Y; Gao X; Chen LR
    Chin Med J (Engl); 2012 Feb; 125(3):450-4. PubMed ID: 22490401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor gene amplification and protein overexpression in basal-like carcinoma of the breast.
    Shao MM; Zhang F; Meng G; Wang XX; Xu H; Yu XW; Chen LY; Tse GM
    Histopathology; 2011 Aug; 59(2):264-73. PubMed ID: 21884205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number.
    Kim MA; Lee HS; Lee HE; Jeon YK; Yang HK; Kim WH
    Histopathology; 2008 May; 52(6):738-46. PubMed ID: 18397279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.
    Young RJ; Rischin D; Fisher R; McArthur GA; Fox SB; Peters LJ; Corry J; Lim A; Waldeck K; Solomon B
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1230-7. PubMed ID: 21467228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology.
    Matsumoto S; Nabeshima K; Kamei T; Hiroshima K; Kawahara K; Hata S; Marukawa K; Matsuno Y; Taguchi K; Tsujimura T
    Cancer Cytopathol; 2013 Aug; 121(8):415-22. PubMed ID: 23450849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of FISH, PCR, and immunohistochemistry in assessing EGFR status in lung adenocarcinoma and correlation with clinicopathologic features.
    El-Zammar OA; Zhang S; Katzenstein AL
    Diagn Mol Pathol; 2009 Sep; 18(3):133-7. PubMed ID: 19704257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma.
    Okuda K; Sasaki H; Kawano O; Yukiue H; Yokoyama T; Yano M; Fujii Y
    J Cancer Res Clin Oncol; 2008 Oct; 134(10):1105-11. PubMed ID: 18392851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas.
    Nakata Y; Uzawa N; Takahashi K; Sumino J; Michikawa C; Sato H; Sonoda I; Ohyama Y; Okada N; Amagasa T
    Eur J Cancer; 2011 Oct; 47(15):2364-72. PubMed ID: 21852109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
    J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased survival in EGFR gene amplified vulvar carcinoma.
    Growdon WB; Boisvert SL; Akhavanfard S; Oliva E; Dias-Santagata DC; Kojiro S; Horowitz NS; Iafrate AJ; Borger DR; Rueda BR
    Gynecol Oncol; 2008 Nov; 111(2):289-97. PubMed ID: 18768215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma.
    Hirayama N; Tabata C; Tabata R; Maeda R; Yasumitsu A; Yamada S; Kuribayashi K; Fukuoka K; Nakano T
    Respir Med; 2011 Jan; 105(1):137-42. PubMed ID: 21041073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.
    Lee HJ; Xu X; Choe G; Chung DH; Seo JW; Lee JH; Lee CT; Jheon S; Sung SW; Chung JH
    Lung Cancer; 2010 Jun; 68(3):375-82. PubMed ID: 19712993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.